Hurvitz: CDK4/6 Inhibitors With Endocrine Therapy Is the “Gold Standard” in the First Line for HR+, HER2-Negative Advanced Breast Cancer

Got To Article
Sara A. Hurvitz, MD, of UCLA Health spoke with The American Journal of Managed Care® (AJMC®) about advanced hormone receptor–positive (HR+), HER2-negative breast cancer and the emergence of CDK4/6 inhibitors with endocrine therapy as the “gold standard” for first-line treatment.
0 comments

New York-based manufacturer of specialty materials moves headquarters to Irving

Got To Article
Alkegen is a privately-owned company with a valuation of nearly $2 billion, backed by Santa Monica, Calif.-based Clearlake Capital Group. The company has 7,000 employees globally, with 1,000 professionals and 6,000 in manufacturing operations. Its new name ...
0 comments

Playtika's Largest Stockholder Exploring Potential Sale of a Portion of its Shares of Playtika

Got To Article
Playtika Holding Corp. (NASDAQ: PLTK) ("Playtika") and its largest stockholder, Playtika Holding UK II Limited ("PHUK II"), announced today that PHUK II has decided to explore options for a potential sale of a portion of the shares of Playtika common stock held by PHUK II.
0 comments

Four dead in ‘ambush’ shooting at LA house party

Got To Article
At least four people were shot dead and one was severely injured near Los Angeles after multiple shooters opened fire at a house party early Sunday, officials said. Mayor James Butt said the reports of shots being fired inside at home on Park Avenue in the Inglewood neighbourhood emerged around 1.
0 comments